292 related articles for article (PubMed ID: 25466924)
1. Bioactive heterocycles containing endocyclic N-hydroxy groups.
Rani R; Granchi C
Eur J Med Chem; 2015 Jun; 97():505-24. PubMed ID: 25466924
[TBL] [Abstract][Full Text] [Related]
2. Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery.
Vila N; Besada P; Costas T; Costas-Lago MC; Terán C
Eur J Med Chem; 2015 Jun; 97():462-82. PubMed ID: 25482553
[TBL] [Abstract][Full Text] [Related]
3. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications.
Kerru N; Gummidi L; Maddila S; Gangu KK; Jonnalagadda SB
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326131
[TBL] [Abstract][Full Text] [Related]
4. One-Step Synthetic Access to Isosteric and Potent Anticancer Nitrogen Heterocycles with the Benzo[c]phenanthridine Scaffold.
Steinhauer TN; Girreser U; Meier C; Cushman M; Clement B
Chemistry; 2016 Jun; 22(24):8301-8. PubMed ID: 27151929
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.
Akhtar J; Khan AA; Ali Z; Haider R; Shahar Yar M
Eur J Med Chem; 2017 Jan; 125():143-189. PubMed ID: 27662031
[TBL] [Abstract][Full Text] [Related]
6. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
[TBL] [Abstract][Full Text] [Related]
7. From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.
Delost MD; Smith DT; Anderson BJ; Njardarson JT
J Med Chem; 2018 Dec; 61(24):10996-11020. PubMed ID: 30024747
[TBL] [Abstract][Full Text] [Related]
8. Bioactive fused heterocycles: Nucleoside analogs with an additional ring.
Jahnz-Wechmann Z; Framski G; Januszczyk P; Boryski J
Eur J Med Chem; 2015 Jun; 97():388-96. PubMed ID: 25576500
[TBL] [Abstract][Full Text] [Related]
9. The Current Status of O-Heterocycles: A Synthetic and Medicinal Overview.
Singh PK; Silakari O
ChemMedChem; 2018 Jun; 13(11):1071-1087. PubMed ID: 29603634
[TBL] [Abstract][Full Text] [Related]
10. Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: synthesis and medicinal significance.
Kvasnica M; Urban M; Dickinson NJ; Sarek J
Nat Prod Rep; 2015 Sep; 32(9):1303-30. PubMed ID: 26030604
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen-containing heterocyclic quinones: a class of potential selective antitumor agents.
Garuti L; Roberti M; Pizzirani D
Mini Rev Med Chem; 2007 May; 7(5):481-9. PubMed ID: 17504183
[TBL] [Abstract][Full Text] [Related]
12. Cancer chemotherapy and heterocyclic compounds.
Kidwai M; Venkataramanan R; Mohan R; Sapra P
Curr Med Chem; 2002 Jun; 9(12):1209-28. PubMed ID: 12052173
[TBL] [Abstract][Full Text] [Related]
13. A versatile strategy for the synthesis of crown ether-bearing heterocycles: discovery of calcium-selective fluoroionophore.
Aoki Y; Umezawa N; Asano Y; Hatano K; Yano Y; Kato N; Higuchi T
Bioorg Med Chem; 2007 Nov; 15(22):7108-15. PubMed ID: 17822906
[TBL] [Abstract][Full Text] [Related]
14. Trends in research of antitrypanosomal agents among synthetic heterocycles.
Kryshchyshyn A; Kaminskyy D; Grellier P; Lesyk R
Eur J Med Chem; 2014 Oct; 85():51-64. PubMed ID: 25072876
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of azaarenes.
Bleeker EA; Wiegman S; de Voogt P; Kraak M; Leslie HA; de Haas E; Admiraal W
Rev Environ Contam Toxicol; 2002; 173():39-83. PubMed ID: 11776750
[TBL] [Abstract][Full Text] [Related]
16. Selection of heterocycles for drug design.
Broughton HB; Watson IA
J Mol Graph Model; 2004 Sep; 23(1):51-8. PubMed ID: 15331053
[TBL] [Abstract][Full Text] [Related]
17. Tandem construction of biological relevant aliphatic 5-membered N-heterocycles.
Łowicki D; Przybylski P
Eur J Med Chem; 2022 May; 235():114303. PubMed ID: 35344904
[TBL] [Abstract][Full Text] [Related]
18. Merging Boron with Nitrogen-Oxygen Bonds: A Review on BON Heterocycles.
Golovanov IS; Sukhorukov AY
Top Curr Chem (Cham); 2021 Feb; 379(2):8. PubMed ID: 33544252
[TBL] [Abstract][Full Text] [Related]
19. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
Rachakonda V; Alla M; Kotipalli SS; Ummani R
Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
[TBL] [Abstract][Full Text] [Related]
20. IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles.
Nair AG; Wong MK; Shu Y; Jiang Y; Jenh CH; Kim SH; Yang DY; Zeng Q; Shao Y; Zawacki LG; Duo J; McGuinness BF; Carroll CD; Hobbs DW; Shih NY; Rosenblum SB; Kozlowski JA
Bioorg Med Chem Lett; 2014 Feb; 24(4):1085-8. PubMed ID: 24486132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
